In Brazil, electronic cigarettes are referred to as DEF (electronic smoking devices), as well as other names such as JUUL, SMOK, e-cigarettes, and electronic cigars. This trend has been present here for some time now. Despite appearing in various forms, the fact is that we are talking about a new form of smoking, which has well-known health risks as well as unknown potential harms. Electronic cigarettes have been banned in Brazil since August 2019, with this decision being made by Anvisa, the National Health Surveillance Agency.
This group of substances can cause various lung injuries, and there is even a specific disease that affects e-cigarette users called Evali, which presents as coughing, shortness of breath, and chest pain, and may be accompanied by abdominal pain, vomiting, diarrhea, and fever. Initially, it may be confused with flu-like illnesses. Evali can worsen and lead to pulmonary fibrosis, pneumonia, and even respiratory failure.
In recent years, a worrying trend has emerged: young people and adolescents are being hospitalized due to respiratory illnesses. As of June of this year, there have been 249 reported cases of Evali in the United States.
Last week, the Brazilian Ministry of Justice ordered 33 companies to temporarily suspend the sale of electronic cigarettes within the country, and imposed fines. It's well known that these cigarettes are more commonly used at concerts, parties, and meetings, with young people being the primary participants.
Statement
This article is compiled from third-party information and is intended for industry-related communication and learning purposes.
This article does not represent the viewpoint of 2FIRSTS and the company cannot confirm the authenticity and accuracy of the article's content. The translation of this article is solely for industry-related communication and research purposes.
Due to limitations in translation capabilities, the translated article may not accurately convey the original meaning. Therefore, please refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on all domestic, Hong Kong, Macau, Taiwan, and foreign-related issues and positions.
Information compiled from this article is owned by the original media source and author. If there is any copyright infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
